Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-059645
Filing Date
2025-06-30
Accepted
2025-06-30 16:06:09
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0245401-10q_bespoke.htm   iXBRL 10-Q 437968
2 CERTIFICATION ea024540101ex31-1_bespoke.htm EX-31.1 11915
3 CERTIFICATION ea024540101ex32-1_bespoke.htm EX-32.1 4298
  Complete submission text file 0001213900-25-059645.txt   3882972

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20250331.xsd EX-101.SCH 32564
5 XBRL CALCULATION FILE bspk-20250331_cal.xml EX-101.CAL 35793
6 XBRL DEFINITION FILE bspk-20250331_def.xml EX-101.DEF 207655
7 XBRL LABEL FILE bspk-20250331_lab.xml EX-101.LAB 363608
8 XBRL PRESENTATION FILE bspk-20250331_pre.xml EX-101.PRE 217454
57 EXTRACTED XBRL INSTANCE DOCUMENT ea0245401-10q_bespoke_htm.xml XML 324896
Mailing Address 12001 E. 33RD ST- UNIT O AURORA CO 80010
Business Address 12001 E. 33RD ST- UNIT O AURORA CO 80010 720-949-1143
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 251092042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)